The first potential mechanism by which FTO polymorphisms affect MetS susceptibility could be that FTO variants cause aberrant expression of the FTO gene, which in turn disturbs the methylation status of FTO-targeted mRNAs and other non-coding RNAs, resulting in metabolic disorders as well as MetS (Figure 2). The gene discussed is FTO; the disease is metabolic disease.